Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ONCYONCY
1 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ONCOLYTICS BIOTECH INC

Yes. Goldman Sachs holds 169,898 shares of ONCY (Oncolytics Biotech), worth $161,386, as of its Q2 2026 13F filing.

Current Value

$161,386

Current Shares

169,898

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
New
169,898
-
$161,3860.0%$0.95
34

Other major holders of ONCY: MARSHALL WACE, LLP, XTX Topco Ltd, SUSQUEHANNA INTERNATIONAL GROUP, LLP, HRT FINANCIAL LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used